OsmoPrep FDA Approval History
FDA Approved: Yes (First approved March 16, 2006)
Brand name: OsmoPrep
Generic name: sodium phosphate monobasic monohydrate and sodium phosphate dibasic anhydrous
Dosage form: Tablets
Previous Name: INKP-102
Company: Salix Pharmaceuticals, Ltd.
Treatment for: Bowel Preparation
OsmoPrep (sodium biphosphate/sodium phosphate) is a bowel cleansing agent in tablet form, indicated for cleansing of the colon as a preparation for colonoscopy.
Development timeline for OsmoPrep
OsmoPrep (sodium phosphate monobasic monohydrate and sodium phosphate dibasic anhydrous) Consumer information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.